The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.
Neuropathology of genetic synucleinopathies with parkinsonism: Review of the literature
Open accessAbstract
Clinical–pathological studies remain the gold‐standard for the diagnosis of Parkinson's disease (PD). However, mounting data from genetic PD autopsies challenge the diagnosis of PD based on Lewy body pathology. Most of the confirmed genetic risks for PD show heterogenous neuropathology, even within kindreds, which may or may not include Lewy body pathology. We review the literature of genetic PD autopsies from cases with molecularly confirmed PD or parkinsonism and summarize main findings on SNCA (n = 25), Parkin (n = 20, 17 bi‐allelic and 3 heterozygotes), PINK1 (n = 5, 1 bi‐allelic and 4 heterozygotes), DJ‐1 (n = 1), LRRK2 (n = 55), GBA (n = 10 Gaucher disease patients with parkinsonism), DNAJC13, GCH1, ATP13A2, PLA2G6 (n = 8 patients, 2 with PD), MPAN (n = 2), FBXO7, RAB39B, and ATXN2 (SCA2), as well as on 22q deletion syndrome (n = 3). Findings from autopsies of heterozygous mutation carriers of genes that are traditionally considered recessively inherited are also discussed. L ewy bodies may be present in syndromes clinically distinctive from PD (eg, MPAN‐related neurodegeneration) and absent in patients with clinical PD syndrome (eg, LRRK2‐PD or Parkin‐PD). Therefore, the authors can conclude that the presence of Lewy bodies are not specific to the diagnosis of PD and that PD can be diagnosed even in the absence of Lewy body pathology. Interventions that reduce alpha‐synuclein load may be more justified in SNCA‐PD or GBA‐PD than in other genetic forms of PD. The number of reported genetic PD autopsies remains small, and there are limited genotype‐clinical‐pathological‐phenotype studies. Therefore, larger series of autopsies from genetic PD patients are required. © 2017 International Parkinson and Movement Disorder Society
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Staging of brain pathology related to sporadic Parkinson’s disease
Braak, H., Tredici, K. D., Rüb, U., de Vos, R. A. I., Jansen Steur, E. N. H., & Braak, E. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00065-9 · Cited by 10,777
Spillantini, M. G., Schmidt, M. L., Lee, V. M.-Y., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997) · Nature · doi:10.1038/42166 · Cited by 8,382
Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease
Krüger, R., Kuhn, W., Müller, T., Woitalla, D., Graeber, M., Kösel, S., Przuntek, H., Epplen, J. T., Schols, L., & Riess, O. (1998) · Nature Genetics · doi:10.1038/ng0298-106 · Cited by 3,836
Phases of Aβ-deposition in the human brain and its relevance for the development of AD
Thal, D. R., Rüb, U., Orantes, M., & Braak, H. (2002) · Neurology · doi:10.1212/wnl.58.12.1791 · Cited by 3,490
Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology
Zimprich, A., Biskup, S., Leitner, P., Lichtner, P., Farrer, M., Lincoln, S., Kachergus, J., Hulihan, M., Uitti, R. J., Calne, D. B., et al. (2004) · Neuron · doi:10.1016/j.neuron.2004.11.005 · Cited by 3,005
Diagnostic Criteria for Parkinson Disease
Gelb, D. J., Oliver, E., & Gilman, S. (1999) · Archives of Neurology · doi:10.1001/archneur.56.1.33 · Cited by 2,822
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
Association between Early-Onset Parkinson's Disease and Mutations in the Parkin Gene
Lücking, C. B., Dürr, A., Bonifati, V., Vaughan, J., De Michele, G., Gasser, T., Harhangi, B. S., Meco, G., Denèfle, P., Wood, N. W., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005253422103 · Cited by 1,433
Healy, D. G., Falchi, M., O'Sullivan, S. S., Bonifati, V., Durr, A., Bressman, S., Brice, A., Aasly, J., Zabetian, C. P., Goldwurm, S., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70117-0 · Cited by 1,425
Neuropathological assessment of Parkinson’s disease: refining the diagnostic criteria
Dickson, D. W., Braak, H., Duda, J. E., Duyckaerts, C., Gasser, T., Halliday, G. M., Hardy, J., Leverenz, J. B., Del Tredici, K., Wszolek, Z. K., et al. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70238-8 · Cited by 972
Parkinson's Disease and Parkinsonism: Neuropathology
Dickson, D. W. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a009258 · Cited by 847
A Mutation in VPS35, Encoding a Subunit of the Retromer Complex, Causes Late-Onset Parkinson Disease
Zimprich, A., Benet-Pagès, A., Struhal, W., Graf, E., Eck, S. H., Offman, M. N., Haubenberger, D., Spielberger, S., Schulte, E. C., Lichtner, P., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.008 · Cited by 816
VPS35 mutations in Parkinson disease
Vilariño-Güell, C., Wider, C., Ross, O. A., Dachsel, J. C., Kachergus, J. M., Lincoln, S. J., Soto-Ortolaza, A. I., Cobb, S. A., Wilhoite, G. J., Bacon, J. A., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.06.001 · Cited by 800
A common LRRK2 mutation in idiopathic Parkinson's disease
Gilks, W. P., Abou-Sleiman, P. M., Gandhi, S., Jain, S., Singleton, A., Lees, A. J., Shaw, K., Bhatia, K. P., Bonifati, V., Quinn, N. P., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17830-1 · Cited by 774
Glucocerebrosidase mutations in clinical and pathologically proven Parkinson’s disease
Neumann, J., Bras, J., Deas, E., O'Sullivan, S. S., Parkkinen, L., Lachmann, R. H., Li, A., Holton, J., Guerreiro, R., Paudel, R., et al. (2009) · Brain · doi:10.1093/brain/awp044 · Cited by 696
Gaucher disease: mutation and polymorphism spectrum in the glucocerebrosidase gene (GBA)
Hruska, K. S., LaMarca, M. E., Scott, C. R., & Sidransky, E. (2008) · Human Mutation · doi:10.1002/humu.20676 · Cited by 678
Alpha‐synuclein p.H50Q, a novel pathogenic mutation for Parkinson's disease
Appel‐Cresswell, S., Vilarino‐Guell, C., Encarnacion, M., Sherman, H., Yu, I., Shah, B., Weir, D., Thompson, C., Szu‐Tu, C., Trinh, J., et al. (2013) · Movement Disorders · doi:10.1002/mds.25421 · Cited by 667
LRRK2 G2019S as a Cause of Parkinson's Disease in Ashkenazi Jews
Ozelius, L. J., Senthil, G., Saunders-Pullman, R., Ohmann, E., Deligtisch, A., Tagliati, M., Hunt, A. L., Klein, C., Henick, B., Hailpern, S. M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmc055509 · Cited by 665
Spira, P. J., Sharpe, D. M., Halliday, G., Cavanagh, J., & Nicholson, G. A. (2001) · Annals of Neurology · doi:10.1002/ana.67 · Cited by 627
(2004) · doi:10.1002/ana.10846 · Cited by 614
Parkinson's Disease Society Brain Bank, London: overview and research.
Daniel, S. E., & Lees, A. J. (1993) · PubMed · Cited by 589
Luoma, P., Melberg, A., Rinne, J. O., Kaukonen, J. A., Nupponen, N. N., Chalmers, R. M., Oldfors, A., Rautakorpi, I., Peltonen, L., Majamaa, K., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16983-3 · Cited by 548
Pasanen, P., Myllykangas, L., Siitonen, M., Raunio, A., Kaakkola, S., Lyytinen, J., Tienari, P. J., Pöyhönen, M., & Paetau, A. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.024 · Cited by 536
Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
Adler, C. H., Beach, T. G., Hentz, J. G., Shill, H. A., Caviness, J. N., Driver-Dunckley, E., Sabbagh, M. N., Sue, L. I., Jacobson, S. A., Belden, C. M., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000641 · Cited by 503
Lewy bodies and parkinsonism in families with parkin mutations
Farrer, M., Chan, P., Chen, R., Tan, L., Lincoln, S., Hernandez, D., Forno, L., Gwinn‐Hardy, K., Petrucelli, L., Hussey, J., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1132 · Cited by 485
Characterization of PLA2G6 as a locus for dystonia‐parkinsonism
Paisan‐Ruiz, C., Bhatia, K. P., Li, A., Hernandez, D., Davis, M., Wood, N. W., Hardy, J., Houlden, H., Singleton, A., & Schneider, S. A. (2009) · Annals of Neurology · doi:10.1002/ana.21415 · Cited by 480
Self-citationHereditary progressive dystonia with marked diurnal fluctuation
Segawa, M., & Nomura, Y. (1991) · Key Topics in Brain Research · doi:10.1007/978-3-7091-9146-0_17 · Cited by 473
Neuropathology provides clues to the pathophysiology of Gaucher disease
Wong, K., Sidransky, E., Verma, A., Mixon, T., Sandberg, G. D., Wakefield, L. K., Morrison, A., Lwin, A., Colegial, C., Allman, J. M., et al. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2004.04.011 · Cited by 452
Lesage, S., Drouet, V., Majounie, E., Deramecourt, V., Jacoupy, M., Nicolas, A., Cormier-Dequaire, F., Hassoun, S. M., Pujol, C., Ciura, S., et al. (2016) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2016.01.014 · Cited by 434
A large kindred with autosomal dominant Parkinson's disease
Golbe, L. I., Di Iorio, G., Bonavita, V., Miller, D. C., & Duvoisin, R. C. (1990) · Annals of Neurology · doi:10.1002/ana.410270309 · Cited by 412
A clinicopathological approach to the diagnosis of dementia
Elahi, F. M., & Miller, B. L. (2017) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.96 · Cited by 412
Brain pathology of spinocerebellar ataxias
Seidel, K., Siswanto, S., Brunt, E. R. P., den Dunnen, W., Korf, H.-W., & Rüb, U. (2012) · Acta Neuropathologica · doi:10.1007/s00401-012-1000-x · Cited by 403
Clinical Correlations With Lewy Body Pathology in LRRK2-Related Parkinson Disease
Kalia, L. V., Lang, A. E., Hazrati, L.-N., Fujioka, S., Wszolek, Z. K., Dickson, D. W., Ross, O. A., Van Deerlin, V. M., Trojanowski, J. Q., Hurtig, H. I., et al. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2014.2704 · Cited by 384
Self-citationMatsumine, H., Saito, M., Shimoda‐Matsubayashi, S., Tanaka, H., Ishikawa, A., Nakagawa-Hattori, Y., Yokochi, M., Kobayashi, T., Igarashi, S., Takano, H., et al. (1997) · Europe PMC (PubMed Central) · Cited by 377
Glucocerebrosidase mutations in subjects with parkinsonism
Lwin, A. (2004) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2003.11.004 · Cited by 371
Pathologic and biochemical studies of juvenile parkinsonism linked to chromosome 6q
Mori, H., Kondo, T., Yokochi, M., Matsumine, H., Nakagawa-Hattori, Y., Miyake, T., Suda, K., & Mizuno, Y. (1998) · Neurology · doi:10.1212/wnl.51.3.890 · Cited by 370
Funayama, M., Ohe, K., Amo, T., Furuya, N., Yamaguchi, J., Saiki, S., Li, Y., Ogaki, K., Ando, M., Yoshino, H., et al. (2015) · The Lancet Neurology · doi:10.1016/s1474-4422(14)70266-2 · Cited by 351
Spira, P. J., Sharpe, D. M., Halliday, G. M., Cavanagh, J., & Nicholson, G. A. (2001) · PubMed · Cited by 343
PINK1 protein in normal human brain and Parkinson's disease
Gandhi, S. (2006) · Brain · doi:10.1093/brain/awl114 · Cited by 342
The Parkinson's disease–linked proteins Fbxo7 and Parkin interact to mediate mitophagy
Burchell, V. S., Nelson, D. E., Sanchez-Martinez, A., Delgado-Camprubi, M., Ivatt, R. M., Pogson, J. H., Randle, S. J., Wray, S., Lewis, P. A., Houlden, H., et al. (2013) · Nature Neuroscience · doi:10.1038/nn.3489 · Cited by 341
Tayebi, N. (2003) · Molecular Genetics and Metabolism · doi:10.1016/s1096-7192(03)00071-4 · Cited by 327
Edvardson, S., Cinnamon, Y., Ta-Shma, A., Shaag, A., Yim, Y.-I., Zenvirt, S., Jalas, C., Lesage, S., Brice, A., Taraboulos, A., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036458 · Cited by 318
Khan, N. L., Jain, S., Lynch, J. M., Pavese, N., Abou-Sleiman, P., Holton, J. L., Healy, D. G., Gilks, W. P., Sweeney, M. G., Ganguly, M., et al. (2005) · Brain · doi:10.1093/brain/awh667 · Cited by 317
DNAJC13 mutations in Parkinson disease
Vilariño-Güell, C., Rajput, A., Milnerwood, A. J., Shah, B., Szu-Tu, C., Trinh, J., Yu, I., Encarnacion, M., Munsie, L. N., Tapia, L., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt570 · Cited by 313
The neuropathology of genetic Parkinson's disease
Poulopoulos, M., Levy, O. A., & Alcalay, R. N. (2012) · Movement Disorders · doi:10.1002/mds.24962 · Cited by 311
Self-citationHow much phenotypic variation can be attributed to parkin genotype?
Lohmann, E., Periquet, M., Bonifati, V., Wood, N. W., De Michele, G., Bonnet, A., Fraix, V., Broussolle, E., Horstink, M. W. I. M., Vidailhet, M., et al. (2003) · Annals of Neurology · doi:10.1002/ana.10613 · Cited by 301
Translation Initiator EIF4G1 Mutations in Familial Parkinson Disease
Chartier-Harlin, M.-C., Dachsel, J. C., Vilariño-Güell, C., Lincoln, S. J., Leprêtre, F., Hulihan, M. M., Kachergus, J., Milnerwood, A. J., Tapia, L., Song, M.-S., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.08.009 · Cited by 299
Lesage, S., Anheim, M., Condroyer, C., Pollak, P., Durif, F., Dupuits, C., Viallet, F., Lohmann, E., Corvol, J.-C., Honoré, A., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddq454 · Cited by 287
Wilson, G. R., Sim, J. C. H., McLean, C., Giannandrea, M., Galea, C. A., Riseley, J. R., Stephenson, S. E. M., Fitzpatrick, E., Haas, S. A., Pope, K., et al. (2014) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2014.10.015 · Cited by 274
Concurrence of α-synuclein and tau brain pathology in the Contursi kindred
Duda, J. E., Giasson, B. I., Mabon, M. E., Miller, D. C., Golbe, L. I., Lee, V. M.-Y., & Trojanowski, J. Q. (2002) · Acta Neuropathologica · doi:10.1007/s00401-002-0563-3 · Cited by 274
Neurodegeneration associated with genetic defects in phospholipase A 2
Gregory, A., Westaway, S. K., Holm, I. E., Kotzbauer, P. T., Hogarth, P., Sonek, S., Coryell, J. C., Nguyen, T. M., Nardocci, N., Zorzi, G., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000327094.67726.28 · Cited by 270
Ross, O. A., Toft, M., Whittle, A. J., Johnson, J. L., Papapetropoulos, S., Mash, D. C., Litvan, I., Gordon, M. F., Wszolek, Z. K., Farrer, M. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20731 · Cited by 268
Hereditary progressive dystonia with marked diurnal fluctuation
Segawa, M. (2000) · Brain and Development · doi:10.1016/s0387-7604(00)00148-0 · Cited by 268
Autosomal dominant parkinsonism associated with variable synuclein and tau pathology
Wszolek, Z. K., Pfeiffer, R. F., Tsuboi, Y., Uitti, R. J., McComb, R. D., Stoessl, A. J., Strongosky, A. J., Zimprich, A., Müller-Myhsok, B., Farrer, M. J., et al. (2004) · Neurology · doi:10.1212/01.wnl.0000125015.06989.db · Cited by 266
Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis
Bras, J., Verloes, A., Schneider, S. A., Mole, S. E., & Guerreiro, R. J. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds089 · Cited by 266
Self-citationHartig, M. B., Iuso, A., Haack, T., Kmiec, T., Jurkiewicz, E., Heim, K., Roeber, S., Tarabin, V., Dusi, S., Krajewska-Walasek, M., et al. (2011) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2011.09.007 · Cited by 264
Familial juvenile Parkinsonism.
Carlier, G., & Jm, D. (1979) · PubMed · Cited by 261
MUTATIONS IN GBA ARE ASSOCIATED WITH FAMILIAL PARKINSON DISEASE SUSCEPTIBILITY AND AGE AT ONSET
Sidransky, E., Samaddar, T., & Tayebi, N. (2009) · Neurology · doi:10.1212/wnl.0b013e3181b28601 · Cited by 259
PINK1-linked parkinsonism is associated with Lewy body pathology
Samaranch, L., Lorenzo-Betancor, O., Arbelo, J. M., Ferrer, I., Lorenzo, E., Irigoyen, J., Pastor, M. A., Marrero, C., Isla, C., Herrera-Henriquez, J., et al. (2010) · Brain · doi:10.1093/brain/awq051 · Cited by 258
Genome-wide Linkage Analysis of a Parkinsonian-Pyramidal Syndrome Pedigree by 500 K SNP Arrays
Shojaee, S., Sina, F., Banihosseini, S. S., Kazemi, M. H., Kalhor, R., Shahidi, G.-A., Fakhrai-Rad, H., Ronaghi, M., & Elahi, E. (2008) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2008.05.005 · Cited by 258
Familial juvenile parkinsonism: Clinical and pathologic study in a family
Takahashi, H., Ohama, E., Suzuki, S., Horikawa, Y., Ishikawa, A., Morita, T., Tsuji, S., & Ikuta, F. (1994) · Neurology · doi:10.1212/wnl.44.3_part_1.437 · Cited by 258
Paisán‐Ruiz, C., Guevara, R., Federoff, M., Hanagasi, H., Sina, F., Elahi, E., Schneider, S. A., Schwingenschuh, P., Bajaj, N., Emre, M., et al. (2010) · Movement Disorders · doi:10.1002/mds.23221 · Cited by 256
Self-citationClinical and pathologic abnormalities in a family with parkinsonism and parkin gene mutations
van de Warrenburg, B. P. C., Lammens, M., Lücking, C. B., Denèfle, P., Wesseling, P., Booij, J., Praamstra, P., Quinn, N., Brice, A., & Horstink, M. W. I. M. (2001) · Neurology · doi:10.1212/wnl.56.4.555 · Cited by 255
Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease
Clark, L. N., Ross, B. M., Wang, Y., Mejia-Santana, H., Harris, J., Louis, E. D., Cote, L. J., Andrews, H., Fahn, S., Waters, C., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000276989.17578.02 · Cited by 252
Schneider, S. A., Edwards, M. J., Mir, P., Cordivari, C., Hooker, J., Dickson, J., Quinn, N., & Bhatia, K. P. (2007) · Movement Disorders · doi:10.1002/mds.21685 · Cited by 247
Self-citationLewy body Parkinson's disease in a large pedigree with 77Parkin mutation carriers
Pramstaller, P. P., Schlossmacher, M. G., Jacques, T. S., Scaravilli, F., Eskelson, C., Pepivani, I., Hedrich, K., Adel, S., Gonzales-McNeal, M., Hilker, R., et al. (2005) · Annals of Neurology · doi:10.1002/ana.20587 · Cited by 247
Biochemical and pathological characterization of Lrrk2
Giasson, B. I., Covy, J. P., Bonini, N. M., Hurtig, H. I., Farrer, M. J., Trojanowski, J. Q., & Van Deerlin, V. M. (2006) · Annals of Neurology · doi:10.1002/ana.20791 · Cited by 238
Ishikawa, A., & Tsuji, S. (1996) · Neurology · doi:10.1212/wnl.47.1.160 · Cited by 233
Glucocerebrosidase mutations are an important risk factor for Lewy body disorders
Goker-Alpan, O., Giasson, B. I., Eblan, M. J., Nguyen, J., Hurtig, H. I., Lee, V. M.-Y., Trojanowski, J. Q., & Sidransky, E. (2006) · Neurology · doi:10.1212/01.wnl.0000230215.41296.18 · Cited by 230
Paisán-Ruiz, C., Li, A., Schneider, S. A., Holton, J. L., Johnson, R., Kidd, D., Chataway, J., Bhatia, K. P., Lees, A. J., Hardy, J., et al. (2012) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2010.05.009 · Cited by 215
Self-citationHayashi, S., Wakabayashi, K., Ishikawa, A., Nagai, H., Saito, M., Maruyama, M., Takahashi, T., Ozawa, T., Tsuji, S., & Takahashi, H. (2000) · Movement Disorders · doi:10.1002/1531-8257(200009)15:5<884::aid-mds1019>3.0.co;2-8 · Cited by 212
Parkinsonism, Lrrk2 G2019S, and tau neuropathology
Rajput, A., Dickson, D. W., Robinson, C. A., Ross, O. A., Dächsel, J. C., Lincoln, S. J., Cobb, S. A., Rajput, M. L., & Farrer, M. J. (2006) · Neurology · doi:10.1212/01.wnl.0000240220.33950.0c · Cited by 211
Autosomal dominant Parkinson's disease caused by SNCA duplications
Konno, T., Ross, O. A., Puschmann, A., Dickson, D. W., & Wszolek, Z. K. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.09.007 · Cited by 210
Glucocerebrosidase Gene Mutations: A Risk Factor for Lewy Body Disorders
Mata, I. F., Samii, A., Schneer, S. H., Roberts, J. W., Griffith, A., Leis, B. C., Schellenberg, G. D., Sidransky, E., Bird, T. D., Leverenz, J. B., et al. (2008) · Archives of Neurology · doi:10.1001/archneurol.2007.68 · Cited by 207
Lrrk2 G2385R is an ancestral risk factor for Parkinson's disease in Asia
Farrer, M. J., Stone, J. T., Lin, C.-H., Dächsel, J. C., Hulihan, M. M., Haugarvoll, K., Ross, O. A., & Wu, R.-M. (2007) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2006.12.001 · Cited by 205
Association of Glucocerebrosidase Mutations With Dementia With Lewy Bodies
Clark, L. N., Kartsaklis, L. A., Wolf Gilbert, R., Dorado, B., Ross, B. M., Kisselev, S., Verbitsky, M., Mejia-Santana, H., Cote, L. J., Andrews, H., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.54 · Cited by 202
Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset
Nichols, W. C., Pankratz, N., Marek, D. K., Pauciulo, M. W., Elsaesser, V. E., Halter, C. A., Rudolph, A., Wojcieszek, J., Pfeiffer, R. F., & Foroud, T. (2009) · Neurology · doi:10.1212/01.wnl.0000327823.81237.d1 · Cited by 202
Parkinson’s disease in GTP cyclohydrolase 1 mutation carriers
Mencacci, N. E., Isaias, I. U., Reich, M. M., Ganos, C., Plagnol, V., Polke, J. M., Bras, J., Hersheson, J., Stamelou, M., Pittman, A. M., et al. (2014) · Brain · doi:10.1093/brain/awu179 · Cited by 201
Hereditary form of parkinsonism—dementia
Muenter, M. D., Forno, L. S., Hornykiewicz, O., Kish, S. J., Maraganore, D. M., Caselli, R. J., Okazaki, H., Howard, F. M., Snow, B. J., & Calne, D. B. (1998) · Annals of Neurology · doi:10.1002/ana.410430612 · Cited by 201
Khan, N. L., Valente, E. M., Bentivoglio, A. R., Wood, N. W., Albanese, A., Brooks, D. J., & Piccini, P. (2002) · Annals of Neurology · doi:10.1002/ana.10417 · Cited by 199
Williams, D. R., Hadeed, A., al‐Din, A. S. N., Wreikat, A., & Lees, A. J. (2005) · Movement Disorders · doi:10.1002/mds.20511 · Cited by 197
ATP13A2 mutations (PARK9) cause neurodegeneration with brain iron accumulation
Schneider, S. A., Paisan‐Ruiz, C., Quinn, N. P., Lees, A. J., Houlden, H., Hardy, J., & Bhatia, K. P. (2010) · Movement Disorders · doi:10.1002/mds.22947 · Cited by 189
Self-citationGwinn-Hardy, K., Mehta, N. D., Farrer, M., Maraganore, D., Muenter, M., Yen, S. H., Hardy, J., & Dickson, D. W. (2000) · Acta Neuropathologica · doi:10.1007/s004010051177 · Cited by 184
Dopa‐responsive dystonia: Pathological and biochemical observations in a case
Rajput, A. H., Gibb, W. R. G., Zhong, X. H., Shannak, K. S., Kish, S., Chang, L. G., & Hornykiewicz, O. (1994) · Annals of Neurology · doi:10.1002/ana.410350405 · Cited by 182
Glucocerebrosidase is present in α-synuclein inclusions in Lewy body disorders
Goker-Alpan, O., Stubblefield, B. K., Giasson, B. I., & Sidransky, E. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0741-7 · Cited by 181
New NBIA subtype: Genetic, clinical, pathologic, and radiographic features of MPAN
Hogarth, P., Gregory, A., Kruer, M. C., Sanford, L., Wagoner, W., Natowicz, M. R., Egel, R. T., Subramony, S. H., Goldman, J. G., Berry-Kravis, E., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e31827e07be · Cited by 178
Linkage mapping of dopa–responsive dystonia (DRD) to chromosome 14q
Nygaard, T. G., Wilhelmsen, K. C., Risch, N. J., Brown, D. L., Trugman, J. M., Conrad Gilliam, T., Fahn, S., & Weeks, D. E. (1993) · Nature Genetics · doi:10.1038/ng1293-386 · Cited by 164
Parkin Disease: A Clinicopathologic Entity?
Doherty, K. M., Silveira-Moriyama, L., Parkkinen, L., Healy, D. G., Farrell, M., Mencacci, N. E., Ahmed, Z., Brett, F. M., Hardy, J., Quinn, N., et al. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.172 · Cited by 163
Butcher, N. J., Kiehl, T.-R., Hazrati, L.-N., Chow, E. W. C., Rogaeva, E., Lang, A. E., & Bassett, A. S. (2013) · JAMA Neurology · doi:10.1001/jamaneurol.2013.3646 · Cited by 159
Self-report psychiatric symptoms in twins and their nontwin relatives: are twins different?
Kendler, K., Martin, N. G., Heath, A. C., & Eaves, L. (1995) · American journal of medical genetics · doi:10.1002/ajmg.1320600622 · Cited by 158
The many faces of alpha‐synuclein mutations
Kasten, M., & Klein, C. (2013) · Movement Disorders · doi:10.1002/mds.25499 · Cited by 157
Patients Homozygous and Heterozygous for SNCA Duplication in a Family With Parkinsonism and Dementia
Ikeuchi, T., Kakita, A., Shiga, A., Kasuga, K., Kaneko, H., Tan, C., Idezuka, J., Wakabayashi, K., Onodera, O., Iwatsubo, T., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.4.514 · Cited by 140
DJ-1 linked parkinsonism (PARK7) is associated with Lewy body pathology
Taipa, R. J. F., Pereira, C., Reis, I., Alonso, I. D. C. M. P., Lima, A. B., Pires, M. M., & Magalhães, M. (2016) · Brain · doi:10.1093/brain/aww080 · Cited by 137
Farias, F., Zeng, R., Johnson, G. S., Wininger, F. A., Taylor, J. F., Schnabel, R. D., McKay, S., Sanders, D. N., Lohi, H., Seppälä, E. H., et al. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.02.009 · Cited by 130
Kiely, A. P., Ling, H., Asi, Y. T., Kara, E., Proukakis, C., Schapira, A. H. V., Morris, H. R., Roberts, H. C., Lubbe, S. J., Limousin, P. D., et al. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0038-3 · Cited by 130
Leucine-Rich Repeat Kinase 2 Gene-Associated Disease: Redefining Genotype-Phenotype Correlation
Wider, C. W., Dickson, D. W., & Wszołek, Z. K. (2010) · Neurodegenerative Diseases · doi:10.1159/000289232 · Cited by 128
Autosomal dominant Lewy body parkinsonism in a four‐generation family
Waters, C., & Miller, C. A. (1994) · Annals of Neurology · doi:10.1002/ana.410350110 · Cited by 127
Hasegawa, K., Stoessl, A. J., Yokoyama, T., Kowa, H., Wszołek, Z. K., & Yagishita, S. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.07.010 · Cited by 118
Striatal biopterin and tyrosine hydroxylase protein reduction in dopa-responsive dystonia
Furukawa, Y., Nygaard, T. G., Gütlich, M., Rajput, A. H., Pifl, C., DiStefano, L., Chang, L. J., Price, K., Shimadzu, M., Hornykiewicz, O., et al. (1999) · Neurology · doi:10.1212/wnl.53.5.1032 · Cited by 117
Clinical spectrum of Kufor‐Rakeb syndrome in the Chilean kindred with ATP13A2 mutations
Behrens, M. I., Brüggemann, N., Chaná, P., Venegas, P., Kägi, M., Parrao, T., Orellana, P., Cristián Garrido, I., Rojas, C., Hauke, J., et al. (2010) · Movement Disorders · doi:10.1002/mds.22996 · Cited by 115
Parkin-positive autosomal recessive juvenile parkinsonism with α-synuclein-positive inclusions
Sasaki, S., Shirata, A., Yamane, K., & Iwata, M. (2004) · Neurology · doi:10.1212/01.wnl.0000134657.25904.0b · Cited by 114
G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies
Gaig, C., Martı́, M. J., Ezquerra, M., Rey, M. J., Cardozo, A., & TOLOSA, E. S. (2007) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2006.107904 · Cited by 112
Clinical, neuropathological and genotypic variability in SNCA A53T familial Parkinson’s disease
Markopoulou, K., Dickson, D. W., McComb, R. D., Wszołek, Z. K., Katechalidou, L., Avery, L. L., Stansbury, M. S., & Chase, B. A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0372-4 · Cited by 110
First appraisal of brain pathology owing to A30P mutant alpha‐synuclein
Seidel, K., Schöls, L. J., Nuber, S., Petrasch‐Parwez, E., Gierga, K., Wszołek, Z. K., Dickson, D. W., Gai, W., Bornemann, A., Rieß, O., et al. (2010) · Annals of Neurology · doi:10.1002/ana.21966 · Cited by 110
Variants associated with Gaucher disease in multiple system atrophy
Mitsui, J., Matsukawa, T., Sasaki, H., Yabe, I., Matsushima, M., Dürr, A., Brice, A., Takashima, H., Kikuchi, A., Aoki, M., et al. (2015) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.185 · Cited by 100
Predictors of Parkin Mutations in Early-Onset Parkinson Disease
Marder, K. S., Tang, M. X., Mejia‐Santana, H., Rosado, L., Louis, E. D., Comella, C. L., Colcher, A., Siderowf, A. D., Jennings, D. L., NANCE, M. A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.95 · Cited by 99
Self-citationThe Glucocerebrosidase Gene and Parkinson's Disease in Ashkenazi Jews
Eblan, M. J., Walker, J. M., & Sidransky, E. (2005) · New England Journal of Medicine · doi:10.1056/nejm200502173520719 · Cited by 96
Brüggemann, N., Hagenah, J. M., Reetz, K., Schmidt, A., Kasten, M., Buchmann, I., Eckerle, S., Bähre, M., Münchau, A. M., Djarmati, A., et al. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.281 · Cited by 93
Dopa-responsive dystonia. Delineation of the clinical syndrome and clues to pathogenesis.
Nygaard, T. G. (1993) · PubMed · Cited by 93
Clark, L. N., Nicolai, A., Afridi, S. K., Harris, J. M., Mejia‐Santana, H., Strug, L. J., COTE, L. J., Louis, E. D., Andrews, H., Waters, C., et al. (2004) · Movement Disorders · doi:10.1002/mds.20320 · Cited by 89
Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2
Orimo, S., Amino, T., Yokochi, M., Kojo, T., Uchihara, T., Takahashi, A., Wakabayashi, K., Takahashi, H., Hattori, N., & Mizuno, Y. (2005) · Movement Disorders · doi:10.1002/mds.20594 · Cited by 87
CLINICOPATHOLOGIC STUDY OF A SNCA GENE DUPLICATION PATIENT WITH PARKINSON DISEASE AND DEMENTIA
Obi, T., Nishioka, K., Ross, O. A., Terada, T., Yamazaki, K., Sugiura, A., Takanashi, M., Mizoguchi, K., Mori, H., Mizuno, Y., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000299387.59159.db · Cited by 85
Complicated recessive dystonia parkinsonism syndromes
Schneider, S. A., Bhatia, K. P., & Hardy, J. (2009) · Movement Disorders · doi:10.1002/mds.22314 · Cited by 75
Self-citationKara, E., Kiely, A. P., Proukakis, C., Giffin, N., Love, S., Hehir, J., Rantell, K. R., Pandraud, A., Hernandez, D. G., Nacheva, E. P., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.994 · Cited by 73
Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2
Martí-Massó, J. F., Ruiz‐Martínez, J., Bolaño, M. J., Ruiz, I., Gorostidi, A., Moreno, F., Ferrer, I., & de Munaín, A. L. (2009) · Movement Disorders · doi:10.1002/mds.22677 · Cited by 72
A new F‐box protein 7 gene mutation causing typical Parkinson's disease
Lohmann, E., Coquel, A., Honoré, A., et al. (2015) · Movement Disorders · doi:10.1002/mds.26266 · Cited by 71
Intralaminar nuclei of the thalamus in Lewy body diseases
Brooks, D., & Halliday, G. M. (2008) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2008.08.014 · Cited by 69
Drouet, V., & Lesage, S. (2014) · BioMed Research International · doi:10.1155/2014/289728 · Cited by 67
GLUCOCEREBROSIDASE MUTATIONS IN 108 NEUROPATHOLOGICALLY CONFIRMED CASES OF MULTIPLE SYSTEM ATROPHY
Segarane, B., Li, A., Paudel, R., Scholz, S. W., Neumann, J., Lees, A. J., Révész, T., Hardy, J., Mathias, C. J., Wood, N. W., et al. (2009) · Neurology · doi:10.1212/01.wnl.0000345356.40399.eb · Cited by 67
Study of a Swiss dopa-responsive dystonia family with a deletion in GCH1
Wider, C. W., Melquist, S., Hauf, M., Solida, A., Cobb, S. A., Kachergus, J. M., Gass, J., Coon, K. D., Baker, M., Cannon, A. D., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000275527.35752.c5 · Cited by 66
Next-generation sequencing reveals substantial genetic contribution to dementia with Lewy bodies
Geiger, J. T., Ding, J., Crain, B. J., Pletniková, O., Letson, C., Dawson, T. M., Rosenthal, L. S., Pantelyat, A. Y., Gibbs, J. R., Albert, M., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.06.004 · Cited by 66
The neuromythology of Parkinson's Disease
Calne, D. B., & Mizuno, Y. (2004) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2004.03.006 · Cited by 65
Hyposmia in G2019S LRRK2-related parkinsonism
Silveira‐Moriyama, L., Guedes, L. C., Kingsbury, A. E., Ayling, H., Shaw, K., Barbosa, E. R., Bonifati, V., Quinn, N. P., Abou‐Sleiman, P. M., Wood, N. W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000326575.20829.45 · Cited by 65
Schöls, L., Reimold, M., Seidel, K., Globas, C., Brockmann, K., Hauser, T., Auburger, G., Bürk, K., den Dunnen, W. D., Reischl, G., et al. (2015) · Brain : a journal of neurology · doi:10.1093/brain/awv255 · Cited by 65
Movement disorders and other motor abnormalities in adults with 22q11.2 deletion syndrome
Boot, E., Butcher, N. J., van Amelsvoort, T., Lang, A. E., Marras, C., Pondal, M., Andrade, D. M., Fung, W. L. A., & Bassett, A. S. (2015) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.36928 · Cited by 63
Steele‐Richardson‐Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein
Morales, B., Martínez, A., Gonzalo, I., Vidal, L., Ros, R., Gómez‐Tortosa, E., Rábano, A., Ampuero, I., Sánchez, M. P., Hoenicka, J., et al. (2002) · Movement Disorders · doi:10.1002/mds.10264 · Cited by 61
Takahashi, H., Ikeuchi, T., Honma, Y., Hayashi, S., & Tsuji, S. (1998) · Acta Neuropathologica · doi:10.1007/s004010050807 · Cited by 61
Dächsel, J. C., Ross, O. A., Mata, I. F., Kachergus, J. M., Toft, M., Cannon, A. D., Baker, M. C., Adamson, J. L., Hutton, M., Dickson, D. W., et al. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0178-1 · Cited by 59
Heterozygote carriers for CNVs inPARK2are at increased risk of Parkinson's disease
Huttenlocher, J., Stefánsson, H., Steinberg, S., Helgadottir, H. T., Sveinbjörnsdóttir, S., Rieß, O., Bauer, P. O., & Stefánsson, K. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv277 · Cited by 55
Puschmann, A., Englund, E. M., Ross, O. A., Vilariño‐Güell, C., Lincoln, S., Kachergus, J. M., Cobb, S. A., Törnqvist, A. L., Rehncrona, S., Widner, H., et al. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.11.019 · Cited by 55
Clinical and pathological characteristics of patients with Leucine‐rich repeat kinase‐2 mutations
Covy, J. P., Yuan, W., Waxman, E. A., Hurtig, H. I., Deerlin, V. M. V., & Giasson, B. I. (2008) · Movement Disorders · doi:10.1002/mds.22096 · Cited by 55
Glucocerebrosidase mutations in diffuse Lewy body disease
Nishioka, K., Ross, O. A., Vilariño‐Güell, C., Cobb, S. A., Kachergus, J. M., Mann, D. M. A., Snowden, J. S., Richardson, A. M. T., Neary, D., Robinson, C. A., et al. (2010) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2010.09.009 · Cited by 55
Frequency of GBA Variants in Autopsy‐proven Multiple System Atrophy
Sklerov, M., Kang, U. J., Liong, C., Clark, L. N., Marder, K. S., Pauciulo, M. W., Nichols, W. C., Chung, W. K., Honig, L. S., Cortes, E. P., et al. (2017) · Movement Disorders Clinical Practice · doi:10.1002/mdc3.12481 · Cited by 53
Self-citationPARK10 is a major locus for sporadic neuropathologically confirmed Parkinson disease
Beecham, G. W., Dickson, D. W., Scott, W. K., Martin, E. R., Schellenberg, G. D., Nuytemans, K., Larson, E. B., Buxbaum, J. D., Trojanowski, J. Q., Deerlin, V. M. V., et al. (2015) · Neurology · doi:10.1212/wnl.0000000000001332 · Cited by 49
Lewy body pathology in a patient with a homozygous Parkin deletion
Miyakawa, S., Ogino, M., Funabe, S., Uchino, A., Shimo, Y., Hattori, N., Ichinoe, M., Mikami, T., Saegusa, M., Nishiyama, K., et al. (2013) · Movement Disorders · doi:10.1002/mds.25346 · Cited by 48
Neuropathology of Parkinson's disease associated with the LRRK2 Ile1371Val mutation
Giordana, M. T., D’Agostino, C., Albani, G., Mauro, A., Fonzo, A. D., Antonini, A., & Bonifati, V. (2006) · Movement Disorders · doi:10.1002/mds.21281 · Cited by 48
Analysis of DNAJC13 mutations in French-Canadian/French cohort of Parkinson's disease
Ross, J. P., Dupré, N., Dauvilliers, Y. A., Strong, S., Ambalavanan, A., Spiegelman, D., Dionne‐Laporte, A., Pourcher, E., Langlois, M., Boivin, M., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.04.023 · Cited by 48
Zhao, T., Severijnen, L.-A. W. F. M., van der Weiden, M., Zheng, P., Oostra, B. A., Hukema, R. K., Willemsen, R., Kros, J. M., & Bonifati, V. (2013) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e318293c586 · Cited by 47
Palin, E., Paetau, A. E., & Suomalainen, A. (2013) · Brain · doi:10.1093/brain/awt160 · Cited by 46
LRRK2 variation and dementia with Lewy bodies
Heckman, M. G., Soto‐Ortolaza, A. I., Sánchez-Contreras, M., Murray, M. E., Pedraza, O., Diehl, N. N., Walton, R. L., Labbé, C., Lorenzo‐Betancor, O., Uitti, R. J., et al. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.07.015 · Cited by 46
Betts, J., Jaros, E., Krishnan, K. J., Perry, R. H., Reeve, A. K., Schaefer, A. M., Taylor, R. W., & Turnbull, D. M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.00981.x · Cited by 45
Glucocerebrosidase mutations do not cause increased Lewy body pathology in Parkinson's disease
Parkkinen, L., Neumann, J., O’Sullivan, S. S., Holton, J. L., Révész, T., Hardy, J., & Lees, A. J. (2011) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2011.04.015 · Cited by 45
Pástor, P., Moreno, F., Clarimón, J., Ruiz, A., Combarros, O., Calero, M., de Munaín, A. L., Bullido, M. J., de Pancorbo, M. M., Carro, E., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150555 · Cited by 43
Riku, Y., Ikeuchi, T., Yoshino, H., Mimuro, M., Mano, K., Goto, Y., Hattori, N., Sobue, G., & Yoshida, M. (2013) · Acta Neuropathologica Communications · doi:10.1186/2051-5960-1-12 · Cited by 43
Autosomal dominant diffuse Lewy body disease
Wakabayashi, K., Hayashi, S., Ishikawa, A., Hayashi, T., Okuizumi, K., Tanaka, H., Tsuji, S., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050883 · Cited by 42
Clinical and Pathological Characteristics of LRRK2 G2019S Patients with PD
Poulopoulos, M., Cortes, E. P., Vonsattel, J., Fahn, S., Waters, C., COTE, L. J., Moskowitz, C. B., Honig, L. S., Clark, L. N., Marder, K. S., et al. (2011) · Journal of Molecular Neuroscience · doi:10.1007/s12031-011-9696-y · Cited by 42
Self-citationGlucosidase-beta variations and Lewy body disorders
Farrer, M. J., Williams, L. N., Algom, A. A., Kachergus, J. M., Hulihan, M., Ross, O. A., Rajput, A. H., Papapetropoulos, S., Mash, D. C., & Dickson, D. W. (2008) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2008.08.004 · Cited by 42
Gaig, C., Ezquerra, M., Martı́, M. J., Valldeoriola, F., Muñoz, E., Lladó, A., Rey, M. J., Cardozo, A., Molinuevo, J. L., & TOLOSA, E. S. (2008) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2008.02.010 · Cited by 38
Gomez, A., & Ferrer, I. (2010) · Acta Neuropathologica · doi:10.1007/s00401-010-0669-y · Cited by 34
Clark, L. N., Kisselev, S., Park, N., Ross, B., Verbitsky, M., Rios, E., Alcalay, R. N., Lee, J. H., & Louis, E. D. (2009) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2009.05.008 · Cited by 32
Self-citationA Peruvian family with a novel PARK2 mutation: Clinical and pathological characteristics
Cornejo‐Olivas, M., Torres, L., Mata, I. F., Mazzetti, P., Rivas, D., Cosentino, C., Inca‐Martinez, M., Cuba, J. M., Zabetian, C. P., & Leverenz, J. B. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.01.005 · Cited by 32
Involvement of spinal motor neurons in parkin‐positive autosomal recessive juvenile parkinsonism
Sasaki, S., Shirata, A., Yamane, K., & Iwata, M. (2007) · Neuropathology · doi:10.1111/j.1440-1789.2007.00829.x · Cited by 10
Young‐onset Parkinson's disease: A clinical pathologic description of two siblings
Tabamo, R. E., Fernandez, H. H., Friedman, J. H., & Simon, D. K. (2000) · Movement Disorders · doi:10.1002/1531-8257(200007)15:4<744::aid-mds1026>3.0.co;2-# · Cited by 7
Cited by
Selective neuronal vulnerability in Parkinson disease
Surmeier, D. J., Obeso, J. A., & Halliday, G. M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2016.178 · Cited by 1,116
Parkinson Disease Epidemiology, Pathology, Genetics, and Pathophysiology
Simon, D. K., Tanner, C. M., & Brundin, P. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.08.002 · Cited by 1,114
Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis
Ma, Q., Xing, C., Long, W., Wang, H. Y., Liu, Q., & Wang, R.-F. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1434-3 · Cited by 748
Siderowf, A., Concha-Marambio, L., Lafontant, D.-E., Farris, C. M., Ma, Y., Urenia, P. A., Nguyen, H., Alcalay, R. N., Chahine, L. M., Foroud, T., et al. (2023) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00109-6 · Cited by 719
Self-citationSimuni, T., Chahine, L. M., Poston, K., Brumm, M., Buracchio, T., Campbell, M., Chowdhury, S., Coffey, C., Concha-Marambio, L., Dam, T., et al. (2024) · The Lancet Neurology · doi:10.1016/s1474-4422(23)00405-2 · Cited by 629
Metadata
- Authors
- Schneider, S. A., & Alcalay, R. N.
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2017-11
- Volume
- 32
- Issue
- 11
- Pages
- 1504-1523
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W2767687660
- Cited by
- 342
- References
- 155
- FWCI
- 16.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.